Press "esc" to clear
Go to Advanced Search

Showing results

110 of 836
NCCN-Patient-Liver-Cancer-2018-small.jpg

Article ID: 696272

New, Reliable Source of Free Information for People with Liver, Gallbladder, or Bile Duct Cancer, Offered by NCCN

National Comprehensive Cancer Network® (NCCN®)

National Comprehensive Cancer Network releases new patient guidelines for liver, gallbladder, and bile duct (hepatobiliary) cancers, sponsored by the Global Liver Institute.

Released:
19-Jun-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 696228

BIDMC Researchers Develop Decision-Making Tool to Benefit Patients with HCV

Beth Israel Deaconess Medical Center

BIDMC researchers led a retrospective analysis of four randomized clinical trials focused on the effects of DAA therapies in patients with HCV-associated liver failure and developed a new means of predicting improvement in liver function in response to DAA treatment.

Released:
18-Jun-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Cortes.jpg
  • Embargo expired:
    16-Jun-2018 2:30 AM EDT

Article ID: 696175

Phase III study shows quizartinib prolongs overall survival for patients with deadly type of relapsed or refractory AML

University of Texas M. D. Anderson Cancer Center

A study led by The University of Texas MD Anderson Cancer Center revealed that the investigational drug quizartinib prolonged overall survival for patients with a deadly form of acute myeloid leukemia (AML) linked to a genetic mutation called FMS-like internal tandem duplications (FLT3-ITD).

Released:
15-Jun-2018 10:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
ScreenShot2018-06-15at4.02.13PM.png

Article ID: 696201

Infectious Disease Experts Available for Comment on Dangers of Swimming in Natural Bodies of Water with Open Wounds or Cuts

University of Alabama at Birmingham

Released:
15-Jun-2018 4:20 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 695919

Algorithm Predicts Dangerous Low Blood Pressure During Surgery

American Society of Anesthesiologists (ASA)

Scientists have developed an algorithm that predicts potentially dangerous low blood pressure, or hypotension, that can occur during surgery. The algorithm identifies hypotension 15 minutes before it occurs in 84 percent of cases, the researchers report in a new study published in the Online First edition of Anesthesiology.

Released:
11-Jun-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Marszalek.jpg
  • Embargo expired:
    11-Jun-2018 11:00 AM EDT

Article ID: 695886

MD Anderson Therapeutics Discovery team identifies and advances a drug that targets metabolic vulnerability and impairs cancer cell growth and survival

University of Texas M. D. Anderson Cancer Center

A drug discovered and advanced by The University of Texas MD Anderson Cancer Center’s Institute for Applied Cancer Science (IACS) and the Center for Co-Clinical Trials (CCCT) inhibits a vital metabolic process required for cancer cells’ growth and survival.

Released:
8-Jun-2018 6:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    11-Jun-2018 8:00 AM EDT

Article ID: 695370

Adapting Lifestyle Habits Can Quickly Lower Blood Pressure

American Society for Nutrition (ASN)

Researchers have demonstrated that a program aimed at helping people modify lifestyle factors such as diet and exercise is as effective as medication at reducing blood pressure.

Released:
4-Jun-2018 8:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
recoded-protein830.jpg

Article ID: 695567

A Change in Bacteria’s Genetic Code Holds Promise of Longer-Lasting Drugs

University of Texas at Austin (UT Austin)

By altering the genetic code in bacteria, researchers at The University of Texas at Austin have demonstrated a method to make therapeutic proteins more stable, an advance that would improve the drugs' effectiveness and convenience

Released:
8-Jun-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    7-Jun-2018 1:05 AM EDT

Article ID: 695556

Half of Hepatitis C Patients with Private Insurance Denied Life-Saving Drugs

Perelman School of Medicine at the University of Pennsylvania

The number of insurance denials for life-saving hepatitis C drugs among patients with both private and public insurers remains high across the United States. Private insurers had the highest denial rates, with 52.4 percent of patients denied coverage, while Medicaid denied 34.5 percent of patients and Medicare denied 14.7 percent.

Released:
4-Jun-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
App2.PNG
  • Embargo expired:
    7-Jun-2018 12:00 AM EDT

Article ID: 695698

Consumers Beware: High User ‘Star Ratings’ Don’t Mean A Mobile Medical App Works (B-roll)

Johns Hopkins Medicine

By screening 250 user reviews and comments for a once popular -- but proven inaccurate -- mobile app claiming to change your iPhone into a blood pressure monitor, Johns Hopkins researchers have added to evidence that a high “star rating” doesn’t necessarily reflect medical accuracy or value.

Released:
6-Jun-2018 1:15 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 836





Chat now!